DOCSLIB.ORG

List of Selected Genes on Scatter Plot: HT-X; HT-MT-Y; HT-Sirna-Z

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
List of Selected Genes on Scatter Plot: HT-X; HT-MT-Y; HT-Sirna-Z List of selected genes on scatter plot: HT-X; HT-MT-Y; HT-siRNA-Z TargetID Signal_ Signal_ Signal_ Symbol Accession Synonyms GO GO GO GI_10047089-S 89.9 103.5 87.3 SMPX NM_014332.1 DNA nucleus striated GI_10047091-S 517.6 748.7 756 NP25 NM_013259.1 NP22 central GI_10047093-S 659.1 725.4 696.9 HSP70-4 NM_016299.1 ATP proteolysis GI_10047099-S 283.9 274.7 242.8 LOC51186 NM_016303.1 DNA nucleus regulation GI_10047103-S 2088.6 2034.1 1908.2 SS18L2 NM_016305.1 KIAA-iso GI_10047105-S 611.3 2625.4 2103.2 CPA4 NM_016352.1 CPA3 carboxype cellular_co histogene GI_10047121-S 89.9 88 93.2 MCFP NM_018843.1 binding mitochond transport GI_10047123-S 875.5 825.4 702.1 LOC55974 NM_018845.1 SCP GI_10047133-A 146.8 158.5 147.4 EB-1 NM_020140.1 AIDA;MGC26087 GI_10047133-I 116.4 141.6 112.7 EB-1 NM_020140.1 AIDA;MGC26087 GI_10092578-S 126.3 140.7 133.1 ITIH3 NM_002217.1 H3P endopepti GI_10092585-S 166.9 186.8 150.3 ZNF236 NM_007345.1 ZNF236A;ZNF236B transcripti nucleus regulation GI_10092596-S 350 410.9 509 MCOLN1 NM_020533.1 ML4;MLIV GI_10092600-S 1119.6 1175.8 1083.2 EIF4G3 NM_003760.2 eIF4GII mRNA eukaryotic regulation GI_10092602-S 155.5 183.9 160 PRG3 NM_006093.2 MBPH sugar immune GI_10092603-S 146 183.7 184.4 C10orf1 NM_020527.1 HUG1 transcripti nucleus transcripti GI_10092611-A 798.4 752.1 875.1 CKLF NM_016326.2 C32;CKLF1;CKLF2;CKLF3;CKLF4;UCK- cytokine integral to chemotaxi GI_10092616-S 135.9 157.5 140.1 PCBP3 NM_020528.1 ALPHA-CP3 nucleic nucleus mRNA GI_10092618-S 911.6 668.6 511.1 NFKBIA NM_020529.1 IKBA;MAD-3;NFKBI transcripti cytoplasm response GI_10092638-S 482.7 659 460.4 CRIM1 NM_016441.1 insulin-like extracellul neurogene GI_10092658-S 162.9 149.1 141.4 FLJ12886 NM_019108.1 F17127_1;DKFZp564H1322 GI_10092668-S 176.1 192.3 186.7 OR2S2 NM_019897.1 OST715 olfactory integral to olfaction GI_10092672-S 949 878.3 802.8 LOC57019 NM_020313.1 GI_10092690-S 122.6 120.1 108.2 TJP3 NM_014428.1 ZO-3 protein tight intracellula GI_10190657-S 107.2 116.3 110.7 HSA404617 NM_018722.1 KCNQ1DN molecular cellular_co biological_ GI_10190665-I 155.8 163.8 141.6 ATP6V0A4 NM_020632.1 a4;Stv1;VPP2;Vph1;RTA1C;RTADR;ATP6N2 GI_10190669-S 108.6 102.7 107.8 GDF3 NM_020634.1 cytokine extracellul cell growth GI_10190671-S 108.4 111 102.3 FGF22 NM_020637.1 GI_10190679-S 417 505.5 444.2 ASCL3 NM_020646.1 DNA nucleus regulation GI_10190681-S 135.8 129.6 142 CBX8 NM_020649.1 PC3;RC1;HPC3 chromatin chromatin chromatin GI_10190685-S 253.8 299.2 254.9 ZNF286 NM_020652.1 KIAA1874 DNA nucleus regulation GI_10190687-S 94.8 88.7 91.8 ZNF287 NM_020653.1 transcripti nucleus regulation GI_10190695-S 158.9 150.4 163.6 ZNF304 NM_020657.1 DNA nucleus regulation GI_10190697-S 128.6 162.7 149.1 CX36 NM_020660.1 GJA9 connexon connexon cell GI_10190699-S 130.6 139.7 139.1 AICDA NM_020661.1 AID;ARP2;CDA2;HIGM2 cytidine cellular_co mRNA GI_10190701-S 170.2 184.8 194.6 MRS2L NM_020662.1 HPT;MRS2 GI_10190705-S 248.9 320.9 289 CLK4 NM_020666.1 ATP nucleus protein GI_10190709-S 95.7 100.9 108.6 LOC57399 NM_020669.1 GI_10190711-S 314.4 415.4 378.4 S100A14 NM_020672.1 BCMP84;S100A15 calcium GI_10190741-S 91.6 103.2 104.6 USP29 NM_020903.1 cysteine- cellular_co ubiquitin- GI_10190743-S 147.9 192.7 121.2 PLEKHA4 NM_020904.1 PEPP1 DNA nucleus regulation GI_10190745-S 600.1 644.9 567.2 RDH14 NM_020905.1 PAN2 oxidoredu metabolis GI_10190747-S 134.1 153 150.8 SCUBE2 NM_020974.1 CEGP1 calcium GI_10198655-S 94.9 97.7 90.5 AMHR2 NM_020547.1 AMHR protein integral to signal GI_10257436-S 332.6 402.6 378 TTYH1 NM_020659.1 iron ion integral to iron ion GI_10280617-S 229.9 296.2 277.8 ATP12A NM_001676.2 ATP1AL1 hydrogen/ hydrogen/ proton GI_10280625-S 193.3 235.7 230.8 APS NM_020979.1 JAK cytoplasm signal GI_10337584-S 110.3 135.6 124.1 DEFA5 NM_021010.1 DEF5;HD-5 antimicrob extracellul antimicrob GI_10337586-S 94.6 87.6 85.2 FGF6 NM_020996.1 HST2;HBGF-6 growth extracellul oncogene GI_10337596-S 212.4 274.3 200.9 SCN2A2 NM_021007.1 HBSCII voltage- voltage- sodium GI_10337606-S 324.6 393.9 465.3 PTTG3 NM_021000.1 GI_10337608-S 479.1 515.5 557.9 CTAG2 NM_020994.1 ESO2;CAMEL;LAGE1;LAGE-1;LAGE- GI_10337610-S 371.4 459.6 393.9 NEUROG3 NM_020999.1 ngn3;Atoh5;Math4B transcripti nucleus peripheral GI_10346128-S 103.4 259.8 110.7 DDX43 NM_018665.1 HAGE;DKFZp434H2114 ATP GI_10346134-S 232.7 445.4 333 MAPRE2 NM_014268.1 EB1;EB2;RP1 microtubul cellular GI_10440557-S 110.1 140.7 131.2 RFPL1 NM_021026.1 RNF78 GI_10440561-S 146.2 181.4 155.3 FHR-3 NM_021023.1 FHR3;HLF4;DOWN16 extracellul GI_10440563-S 116.5 122.6 115 TLX3 NM_021025.1 RNX;HOX11L2 transcripti nucleus regulation GI_10440565-S 141.1 187.4 138.7 LZTS1 NM_021020.1 F37;FEZ1 transcripti GI_10442821-S 578.6 612.4 598.7 BIRC6 NM_016252.1 KIAA1289 cysteine intracellula ubiquitin GI_10518496-S 159.6 156.3 146.2 DLL1 NM_005618.2 DELTA1 structural extracellul cell GI_10518498-S 1051.6 1169.5 690.2 RNF24 NM_007219.2 G1L GI_10518499-S 199.7 339.4 176.9 F3 NM_001993.2 TF;TFA;CD142 blood integral to blood GI_10518500-S 165.3 192.4 162.2 F5 NM_000130.2 FVL;PCCF blood blood GI_10518501-I 91.5 107.5 97.4 F7 NM_000131.2 serine- extracellul blood GI_10518502-A 172.6 205.3 180.5 F7 NM_019616.1 serine- extracellul blood GI_10518504-I 100.3 88.6 92.9 F8 NM_000132.2 AHF;F8B;F8C;HEMA;FVIII;DXS1253E blood blood GI_10518505-A 433.3 538 520.1 F8 NM_019863.1 AHF;F8B;F8C;HEMA;FVIII;DXS1253E blood blood GI_10518505-I 169.3 187.1 183.3 F8 NM_019863.1 AHF;F8B;F8C;HEMA;FVIII;DXS1253E blood blood GI_10518507-S 94.9 99.5 102.7 F9 NM_000133.2 FIX;PTC;HEMB blood extracellul blood GI_10567815-I 171.3 208.8 193.5 GNAO1 NM_020988.1 GNAO;G-ALPHA-o heterotrim peripheral axon GI_10567821-S 98.4 101.9 91.1 ZNF253 NM_021047.1 BMZF1;BMZF-1;FLJ90391 zinc ion nucleus regulation GI_10567823-S 151.1 184.9 167.5 LOC57830 NM_021046.1 structural intermedia biological_ GI_10645198-S 96.6 99.7 97.1 ADAMTS7 NM_014272.1 ADAM-TS7;DKFZp434H204 metallope extracellul proteolysis GI_10800141-S 146.2 169.7 150.2 IFNA7 NM_021057.1 IFNA-J interferon- extracellul response GI_10800147-S 238.9 263.9 230.9 KIAA0186 NM_021067.1 GI_10800407-S 112.1 112.2 103 CGA NM_000735.2 HCG;LHA;FSHA;GPHa;TSHA;GPHA1;CG- hormone soluble signal GI_10800411-S 325.1 496.1 514.7 MAPRE3 NM_012326.2 EB3;RP3;EBF3 microtubul microtubul GI_10800413-S 485.8 573.6 523.9 SC5DL NM_006918.2 ERG3;SC5D C-5 sterol endoplas lipid GI_10800414-S 172.3 255.5 747.8 NDN NM_002487.2 HsT16328 DNA nucleus negative GI_10800415-S 1091.6 1250.8 807.7 SCG2 NM_003469.2 CHGC;SgII calcium secretory protein GI_10800416-S 425.3 561 483.6 BRAP NM_006768.2 IMP;BRAP2;RNF52 nuclear soluble nucleocyto GI_10800418-S 228.3 282.1 248.3 CHGA NM_001275.2 CGA calcium synaptic regulation GI_10801344-S 8363.6 8084.4 6790.3 eIF3k NM_013234.1 M9;ARG134;PTD001;HSPC029;PLAC- GI_10834965-S 2262.2 2409 2245.1 GLB1 NM_000404.1 beta- lysosome GI_10834967-S 280.9 320.5 316.7 MAN2B1 NM_000528.1 MANB;LAMAN alpha- lysosome protein GI_10834979-S 106.7 117.5 93.8 IL9 NM_000590.1 P40;HP40;IL-9 interleukin- extracellul positive GI_10834981-S 94.1 105 99.9 IGFBP5 NM_000599.1 IBP5 insulin-like extracellul signal GI_10834983-S 230.4 326.5 172.6 IL6 NM_000600.1 HGF;HSF;BSF2;IL-6;IFNB2 interleukin- extracellul negative GI_10834989-A 165.9 217.9 125.5 NCAM1 NM_000615.1 CD56;NCAM;MSK39 cell integral to synaptic GI_10834999-S 124.4 139.3 128.6 PNLIP NM_000936.1 triacylglyc triacylglyc GI_10835001-S 2819.9 1383 270.4 ARHGDIB NM_001175.1 D4;GDIA2;GDID4;LYGDI;RAP1GN1 Rho GDP- cytoplasmi negative GI_10835009-S 694.4 870.5 585.5 CTNND1 NM_001331.1 CAS;CTNND;P120CAS;P120CTN;KIAA0384 structural kinesin cell GI_10835012-S 111.1 126.2 118.1 ESR2 NM_001437.1 Erb;ESRB;NR3A2;ER-BETA;ESR-BETA steroid nucleus signal GI_10835020-S 294.3 361.9 304.1 IGFBP4 NM_001552.1 IBP4 insulin-like extracellul skeletal GI_10835022-S 1733.8 1146.9 1101.4 ITPR1 NM_002222.1 IP3R;IP3R1;Insp3r1 inositol- endoplas small GI_10835024-S 5232.7 7320.5 6048.4 NDUFV2 NM_021074.1 iron-sulfur NADH mitochond GI_10835040-S 237.9 288.9 256 ZNF202 NM_003455.1 specific nucleus lipid GI_10835046-S 1711.7 1868.1 1400.2 SGCE NM_003919.1 ESG;DYT11 sarcoglyca muscle GI_10835048-S 8196 9678.8 7287.9 ARHA NM_001664.1 RHOA;ARH12;RHO12;RHOH12 Rho small cytoskelet Rho GI_10835070-S 174.7 933.7 232.6 CD74 NM_004355.1 DHLAG;HLADG;Ia-GAMMA class II integral to immune GI_10835082-S 139 162.6 148 RS1 NM_000330.1 RS;XLRS1 cell extracellul vision GI_10835084-S 1084.6 894.1 1459.1 MT1H NM_005951.1 MT1 heavy GI_10835092-S 1451.6 1707.6 1685.4 PTTG2 NM_006607.1 GI_10835094-S 562.6 531 490.2 SAA4 NM_006512.1 CSAA amyloid extracellul acute- GI_10835100-S 457.2 549.6 628.5 GCN5L2 NM_021078.1 GCN5 transcripti nucleoso protein GI_10835102-S 87.8 87.9 90 IFNA4 NM_021068.1 INFA4 interferon- extracellul response GI_10835118-S 611.3 647 631.7 MYO5A NM_000259.1 GS1;MYO5;MYH12;MYOXIN myosin kinesin nonselecti GI_10835134-S 103.6 129.6 119.2 CRP NM_000567.1 PTX1 binding extracellul inflammat GI_10835138-S 117 121.7 122.4 FCGR3B NM_000570.1 CD16;FCG3;FCGR3 receptor immune GI_10835156-S 107.1 261.8 103.3 IGFBP2 NM_000597.1 IBP2 GI_10835158-S 2265.2 3582.8 3677 SERPINE1 NM_000602.1 PAI;PAI1;PAI-1;PLANH1 endopepti blood GI_10835168-S 673.5 670.1 984.9 SLC11A2 NM_000617.1 DCT1;DMT1;NRAMP2 iron ion integral to iron ion GI_10835170-S 131.7 164.4 129.1 IFNG NM_000619.1 IFG;IFI interferon- extracellul cell GI_10835172-S 120.4 150.4 124.3 NOS1 NM_000620.1 NOS nitric- membran synaptic GI_10835174-S 199.8 216.5 195.9 HTR2A NM_000621.1 HTR2 serotonin integral to serotonin GI_10835182-S 149.8 166.6 173.2 IFNAR1 NM_000629.1 AVP;IFRC;IFNAR;IFNBR interferon- integral to JAK-STAT GI_10835186-S 475.2
Load more

Recommended publications
  • Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse
    Welcome to More Choice CD Marker Handbook For more information, please visit: Human bdbiosciences.com/eu/go/humancdmarkers Mouse bdbiosciences.com/eu/go/mousecdmarkers Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse CD3 CD3 CD (cluster of differentiation) molecules are cell surface markers T Cell CD4 CD4 useful for the identification and characterization of leukocytes. The CD CD8 CD8 nomenclature was developed and is maintained through the HLDA (Human Leukocyte Differentiation Antigens) workshop started in 1982. CD45R/B220 CD19 CD19 The goal is to provide standardization of monoclonal antibodies to B Cell CD20 CD22 (B cell activation marker) human antigens across laboratories. To characterize or “workshop” the antibodies, multiple laboratories carry out blind analyses of antibodies. These results independently validate antibody specificity. CD11c CD11c Dendritic Cell CD123 CD123 While the CD nomenclature has been developed for use with human antigens, it is applied to corresponding mouse antigens as well as antigens from other species. However, the mouse and other species NK Cell CD56 CD335 (NKp46) antibodies are not tested by HLDA. Human CD markers were reviewed by the HLDA. New CD markers Stem Cell/ CD34 CD34 were established at the HLDA9 meeting held in Barcelona in 2010. For Precursor hematopoetic stem cell only hematopoetic stem cell only additional information and CD markers please visit www.hcdm.org. Macrophage/ CD14 CD11b/ Mac-1 Monocyte CD33 Ly-71 (F4/80) CD66b Granulocyte CD66b Gr-1/Ly6G Ly6C CD41 CD41 CD61 (Integrin b3) CD61 Platelet CD9 CD62 CD62P (activated platelets) CD235a CD235a Erythrocyte Ter-119 CD146 MECA-32 CD106 CD146 Endothelial Cell CD31 CD62E (activated endothelial cells) Epithelial Cell CD236 CD326 (EPCAM1) For Research Use Only.
    [Show full text]
  • SF3B3) and Sin3a Associated Protein 130 (SAP130
    cells Communication Ambiguity about Splicing Factor 3b Subunit 3 (SF3B3) and Sin3A Associated Protein 130 (SAP130) Paula I. Metselaar 1,* , Celine Hos 1, Olaf Welting 1, Jos A. Bosch 2,3, Aletta D. Kraneveld 4 , Wouter J. de Jonge 1 and Anje A. Te Velde 1 1 Tytgat Institute for Liver and Intestinal Research, AGEM, Amsterdam UMC, University of Amsterdam, 1105BK Amsterdam, The Netherlands; [email protected] (C.H.); [email protected] (O.W.); [email protected] (W.J.d.J.); [email protected] (A.A.T.V.) 2 Department of Psychology, University of Amsterdam, 1018WS Amsterdam, The Netherlands; [email protected] 3 Department of Medical Psychology, Amsterdam UMC, University of Amsterdam, 1001NK Amsterdam, The Netherlands 4 Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, 3584CG Utrecht, The Netherlands; [email protected] * Correspondence: [email protected] Abstract: In 2020, three articles were published on a protein that can activate the immune system by binding to macrophage-inducible C-type lectin receptor (Mincle). In the articles, the protein was referred to as ‘SAP130, a subunit of the histone deacetylase complex.’ However, the Mincle ligand the authors aimed to investigate is splicing factor 3b subunit 3 (SF3B3). This splicing factor is unrelated to SAP130 (Sin3A associated protein 130, a subunit of the histone deacetylase-dependent Sin3A corepressor complex). The conclusions in the three articles were formulated for SF3B3, Citation: Metselaar, P.I.; Hos, C.; while the researchers used qPCR primers and antibodies against SAP130.
    [Show full text]
  • Molecular Mechanisms Involved Involved in the Interaction Effects of HCV and Ethanol on Liver Cirrhosis
    Virginia Commonwealth University VCU Scholars Compass Theses and Dissertations Graduate School 2010 Molecular Mechanisms Involved Involved in the Interaction Effects of HCV and Ethanol on Liver Cirrhosis Ryan Fassnacht Virginia Commonwealth University Follow this and additional works at: https://scholarscompass.vcu.edu/etd Part of the Physiology Commons © The Author Downloaded from https://scholarscompass.vcu.edu/etd/2246 This Thesis is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact [email protected]. Ryan C. Fassnacht 2010 All Rights Reserved Molecular Mechanisms Involved in the Interaction Effects of HCV and Ethanol on Liver Cirrhosis A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science at Virginia Commonwealth University. by Ryan Christopher Fassnacht, B.S. Hampden Sydney University, 2005 M.S. Virginia Commonwealth University, 2010 Director: Valeria Mas, Ph.D., Associate Professor of Surgery and Pathology Division of Transplant Department of Surgery Virginia Commonwealth University Richmond, Virginia July 9, 2010 Acknowledgement The Author wishes to thank his family and close friends for their support. He would also like to thank the members of the molecular transplant team for their help and advice. This project would not have been possible with out the help of Dr. Valeria Mas and her endearing
    [Show full text]
  • Sorting Nexins in Protein Homeostasis Sara E. Hanley1,And Katrina F
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 6 November 2020 doi:10.20944/preprints202011.0241.v1 Sorting nexins in protein homeostasis Sara E. Hanley1,and Katrina F. Cooper2* 1Department of Molecular Biology, Graduate School of Biomedical Sciences, Rowan University, Stratford, NJ, 08084, USA 1 [email protected] 2 [email protected] * [email protected] Tel: +1 (856)-566-2887 1Department of Molecular Biology, Graduate School of Biomedical Sciences, Rowan University, Stratford, NJ, 08084, USA Abstract: Sorting nexins (SNXs) are a highly conserved membrane-associated protein family that plays a role in regulating protein homeostasis. This family of proteins is unified by their characteristic phox (PX) phosphoinositides binding domain. Along with binding to membranes, this family of SNXs also comprises a diverse array of protein-protein interaction motifs that are required for cellular sorting and protein trafficking. SNXs play a role in maintaining the integrity of the proteome which is essential for regulating multiple fundamental processes such as cell cycle progression, transcription, metabolism, and stress response. To tightly regulate these processes proteins must be expressed and degraded in the correct location and at the correct time. The cell employs several proteolysis mechanisms to ensure that proteins are selectively degraded at the appropriate spatiotemporal conditions. SNXs play a role in ubiquitin-mediated protein homeostasis at multiple levels including cargo localization, recycling, degradation, and function. In this review, we will discuss the role of SNXs in three different protein homeostasis systems: endocytosis lysosomal, the ubiquitin-proteasomal, and the autophagy-lysosomal system. The highly conserved nature of this protein family by beginning with the early research on SNXs and protein trafficking in yeast and lead into their important roles in mammalian systems.
    [Show full text]
  • Systems Analysis Implicates WAVE2&Nbsp
    JACC: BASIC TO TRANSLATIONAL SCIENCE VOL.5,NO.4,2020 ª 2020 THE AUTHORS. PUBLISHED BY ELSEVIER ON BEHALF OF THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION. THIS IS AN OPEN ACCESS ARTICLE UNDER THE CC BY-NC-ND LICENSE (http://creativecommons.org/licenses/by-nc-nd/4.0/). PRECLINICAL RESEARCH Systems Analysis Implicates WAVE2 Complex in the Pathogenesis of Developmental Left-Sided Obstructive Heart Defects a b b b Jonathan J. Edwards, MD, Andrew D. Rouillard, PHD, Nicolas F. Fernandez, PHD, Zichen Wang, PHD, b c d d Alexander Lachmann, PHD, Sunita S. Shankaran, PHD, Brent W. Bisgrove, PHD, Bradley Demarest, MS, e f g h Nahid Turan, PHD, Deepak Srivastava, MD, Daniel Bernstein, MD, John Deanfield, MD, h i j k Alessandro Giardini, MD, PHD, George Porter, MD, PHD, Richard Kim, MD, Amy E. Roberts, MD, k l m m,n Jane W. Newburger, MD, MPH, Elizabeth Goldmuntz, MD, Martina Brueckner, MD, Richard P. Lifton, MD, PHD, o,p,q r,s t d Christine E. Seidman, MD, Wendy K. Chung, MD, PHD, Martin Tristani-Firouzi, MD, H. Joseph Yost, PHD, b u,v Avi Ma’ayan, PHD, Bruce D. Gelb, MD VISUAL ABSTRACT Edwards, J.J. et al. J Am Coll Cardiol Basic Trans Science. 2020;5(4):376–86. ISSN 2452-302X https://doi.org/10.1016/j.jacbts.2020.01.012 JACC: BASIC TO TRANSLATIONALSCIENCEVOL.5,NO.4,2020 Edwards et al. 377 APRIL 2020:376– 86 WAVE2 Complex in LVOTO HIGHLIGHTS ABBREVIATIONS AND ACRONYMS Combining CHD phenotype–driven gene set enrichment and CRISPR knockdown screening in zebrafish is an effective approach to identifying novel CHD genes.
    [Show full text]
  • Polymerase Ribozyme with Promoter Recognition
    In vitro Evolution of a Processive Clamping RNA Polymerase Ribozyme with Promoter Recognition by Razvan Cojocaru BSc, Simon Fraser University, 2014 Thesis Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy in the Department of Molecular Biology and Biochemistry Faculty of Science © Razvan Cojocaru 2021 SIMON FRASER UNIVERSITY Summer 2021 Copyright in this work is held by the author. Please ensure that any reproduction or re-use is done in accordance with the relevant national copyright legislation. Declaration of Committee Name: Razvan Cojocaru Degree: Doctor of Philosophy Title: In vitro Evolution of a Processive Clamping RNA Polymerase Ribozyme with Promoter Recognition Committee: Chair: Lisa Craig Professor, Molecular Biology and Biochemistry Peter Unrau Supervisor Professor, Molecular Biology and Biochemistry Dipankar Sen Committee Member Professor, Molecular Biology and Biochemistry Michel Leroux Committee Member Professor, Molecular Biology and Biochemistry Mani Larijani Internal Examiner Associate Professor, Molecular Biology and Biochemistry Gerald Joyce External Examiner Professor, Jack H. Skirball Center for Chemical Biology and Proteomics Salk Institute for Biological Studies Date Defended/Approved: August 12, 2021 ii Abstract The RNA World hypothesis proposes that the early evolution of life began with RNAs that can serve both as carriers of genetic information and as catalysts. Later in evolution, these functions were gradually replaced by DNA and enzymatic proteins in cellular biology. I start by reviewing the naturally occurring catalytic RNAs, ribozymes, as they play many important roles in biology today. These ribozymes are central to protein synthesis and the regulation of gene expression, creating a landscape that strongly supports an early RNA World.
    [Show full text]
  • Yeast Genome Gazetteer P35-65
    gazetteer Metabolism 35 tRNA modification mitochondrial transport amino-acid metabolism other tRNA-transcription activities vesicular transport (Golgi network, etc.) nitrogen and sulphur metabolism mRNA synthesis peroxisomal transport nucleotide metabolism mRNA processing (splicing) vacuolar transport phosphate metabolism mRNA processing (5’-end, 3’-end processing extracellular transport carbohydrate metabolism and mRNA degradation) cellular import lipid, fatty-acid and sterol metabolism other mRNA-transcription activities other intracellular-transport activities biosynthesis of vitamins, cofactors and RNA transport prosthetic groups other transcription activities Cellular organization and biogenesis 54 ionic homeostasis organization and biogenesis of cell wall and Protein synthesis 48 plasma membrane Energy 40 ribosomal proteins organization and biogenesis of glycolysis translation (initiation,elongation and cytoskeleton gluconeogenesis termination) organization and biogenesis of endoplasmic pentose-phosphate pathway translational control reticulum and Golgi tricarboxylic-acid pathway tRNA synthetases organization and biogenesis of chromosome respiration other protein-synthesis activities structure fermentation mitochondrial organization and biogenesis metabolism of energy reserves (glycogen Protein destination 49 peroxisomal organization and biogenesis and trehalose) protein folding and stabilization endosomal organization and biogenesis other energy-generation activities protein targeting, sorting and translocation vacuolar and lysosomal
    [Show full text]
  • Loss of Fam60a, a Sin3a Subunit, Results in Embryonic Lethality and Is Associated with Aberrant Methylation at a Subset of Gene
    RESEARCH ARTICLE Loss of Fam60a, a Sin3a subunit, results in embryonic lethality and is associated with aberrant methylation at a subset of gene promoters Ryo Nabeshima1,2, Osamu Nishimura3,4, Takako Maeda1, Natsumi Shimizu2, Takahiro Ide2, Kenta Yashiro1†, Yasuo Sakai1, Chikara Meno1, Mitsutaka Kadota3,4, Hidetaka Shiratori1†, Shigehiro Kuraku3,4*, Hiroshi Hamada1,2* 1Developmental Genetics Group, Graduate School of Frontier Biosciences, Osaka University, Suita, Japan; 2Laboratory for Organismal Patterning, RIKEN Center for Developmental Biology, Kobe, Japan; 3Phyloinformatics Unit, RIKEN Center for Life Science Technologies, Kobe, Japan; 4Laboratory for Phyloinformatics, RIKEN Center for Biosystems Dynamics Research, Kobe, Japan Abstract We have examined the role of Fam60a, a gene highly expressed in embryonic stem cells, in mouse development. Fam60a interacts with components of the Sin3a-Hdac transcriptional corepressor complex, and most Fam60a–/– embryos manifest hypoplasia of visceral organs and die in utero. Fam60a is recruited to the promoter regions of a subset of genes, with the expression of these genes being either up- or down-regulated in Fam60a–/– embryos. The DNA methylation level of the Fam60a target gene Adhfe1 is maintained at embryonic day (E) 7.5 but markedly reduced at –/– *For correspondence: E9.5 in Fam60a embryos, suggesting that DNA demethylation is enhanced in the mutant. [email protected] (SK); Examination of genome-wide DNA methylation identified several differentially methylated regions, [email protected] (HH) which were preferentially hypomethylated, in Fam60a–/– embryos. Our data suggest that Fam60a is †These authors contributed required for proper embryogenesis, at least in part as a result of its regulation of DNA methylation equally to this work at specific gene promoters.
    [Show full text]
  • Flow Reagents Single Color Antibodies CD Chart
    CD CHART CD N° Alternative Name CD N° Alternative Name CD N° Alternative Name Beckman Coulter Clone Beckman Coulter Clone Beckman Coulter Clone T Cells B Cells Granulocytes NK Cells Macrophages/Monocytes Platelets Erythrocytes Stem Cells Dendritic Cells Endothelial Cells Epithelial Cells T Cells B Cells Granulocytes NK Cells Macrophages/Monocytes Platelets Erythrocytes Stem Cells Dendritic Cells Endothelial Cells Epithelial Cells T Cells B Cells Granulocytes NK Cells Macrophages/Monocytes Platelets Erythrocytes Stem Cells Dendritic Cells Endothelial Cells Epithelial Cells CD1a T6, R4, HTA1 Act p n n p n n S l CD99 MIC2 gene product, E2 p p p CD223 LAG-3 (Lymphocyte activation gene 3) Act n Act p n CD1b R1 Act p n n p n n S CD99R restricted CD99 p p CD224 GGT (γ-glutamyl transferase) p p p p p p CD1c R7, M241 Act S n n p n n S l CD100 SEMA4D (semaphorin 4D) p Low p p p n n CD225 Leu13, interferon induced transmembrane protein 1 (IFITM1). p p p p p CD1d R3 Act S n n Low n n S Intest CD101 V7, P126 Act n p n p n n p CD226 DNAM-1, PTA-1 Act n Act Act Act n p n CD1e R2 n n n n S CD102 ICAM-2 (intercellular adhesion molecule-2) p p n p Folli p CD227 MUC1, mucin 1, episialin, PUM, PEM, EMA, DF3, H23 Act p CD2 T11; Tp50; sheep red blood cell (SRBC) receptor; LFA-2 p S n p n n l CD103 HML-1 (human mucosal lymphocytes antigen 1), integrin aE chain S n n n n n n n l CD228 Melanotransferrin (MT), p97 p p CD3 T3, CD3 complex p n n n n n n n n n l CD104 integrin b4 chain; TSP-1180 n n n n n n n p p CD229 Ly9, T-lymphocyte surface antigen p p n p n
    [Show full text]
  • Predicting Clinical Response to Treatment with a Soluble Tnf-Antagonist Or Tnf, Or a Tnf Receptor Agonist
    (19) TZZ _ __T (11) EP 2 192 197 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 02.06.2010 Bulletin 2010/22 C12Q 1/68 (2006.01) (21) Application number: 08170119.5 (22) Date of filing: 27.11.2008 (84) Designated Contracting States: (72) Inventor: The designation of the inventor has not AT BE BG CH CY CZ DE DK EE ES FI FR GB GR yet been filed HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR (74) Representative: Habets, Winand Designated Extension States: Life Science Patents AL BA MK RS PO Box 5096 6130 PB Sittard (NL) (71) Applicant: Vereniging voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek en Patiëntenzorg 1081 HV Amsterdam (NL) (54) Predicting clinical response to treatment with a soluble tnf-antagonist or tnf, or a tnf receptor agonist (57) The invention relates to methods for predicting a clinical response to a therapy with a soluble TNF antagonist, TNF or a TNF receptor agonist and a kit for use in said methods. EP 2 192 197 A1 Printed by Jouve, 75001 PARIS (FR) EP 2 192 197 A1 Description [0001] The invention relates to methods for predicting a clinical response to a treatment with a soluble TNF antagonist, with TNF or a TNF receptor agonist using expression levels of genes of the Type I INF pathway and a kit for use in said 5 methods. In another aspect, the invention relates to a method for evaluating a pharmacological effect of a treatment with a soluble TNF antagonist, TNF or a TNF receptor agonist.
    [Show full text]
  • (Gefs & Gaps) of the Rho Family
    Structural and biochemical investigation of the activity, specificity and regulation of regulators (GEFs & GAPs) of the Rho family Inaugural-Dissertation zur Erlangung des Doktorgrades der Mathematisch-Naturwissenschaftlichen Fakultät der Heinrich-Heine-Universität Düsseldorf vorgelegt von Mamta Jaiswal aus Indien Düsseldorf, November 2012 Aus dem Institut für Biochemie und Molekularbiologie II der Heinrich-Heine-Universität Düsseldorf Gedruckt mit der Genehmigung der Mathematisch-Naturwissenschaftlichen Fakultät der Heinrich-Heine-Universität Düsseldorf Referent: PD. Dr. Reza Ahmadian Koreferent: Prof. Dr. Dieter Willbold Tag der mündlichen Prüfung: 23.01.2013 Eidesstattliche Erklärung Hiermit erkläre ich an Eides statt, dass ich die hier vorgelegte Dissertation eigenständig und ohne unerlaubte Hilfe angefertigt habe. Es wurden keinerlei andere Quellen und Hilfsmittel, außer den angegebenen, benutzt. Zitate aus anderen Arbeiten wurden kenntlich gemacht. Diese Dissertation wurde in der vorgelegten oder einer ähnlichen Form noch bei keiner anderen Institution eingereicht und es wurden bisher keine erfolglosen Promotionsversuche von mir unternommen. Düsseldorf, im November 2012 To my family Table of Contents Table of Contents TABLE OF CONTENTS .................................................................................................. I TABLE OF FIGURES .................................................................................................... III PUBLICATIONS ...........................................................................................................
    [Show full text]
  • University of Cincinnati
    UNIVERSITY OF CINCINNATI Date: 1-Oct-2010 I, Jason Matthew Puglise , hereby submit this original work as part of the requirements for the degree of: Doctor of Philosophy in Cell & Molecular Biology It is entitled: Roles of the Rac/Cdc42 effector proteins Pak and PIX in cytokinesis, ciliogenesis, and cyst formation in renal epithelial cells Student Signature: Jason Matthew Puglise This work and its defense approved by: Committee Chair: Robert Brackenbury, PhD Robert Brackenbury, PhD 11/1/2010 1,117 Roles of the Rac/Cdc42 effector proteins Pak and PIX in cytokinesis, ciliogenesis, and cyst formation in renal epithelial cells A dissertation submitted to the Graduate School of the University of Cincinnati in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Graduate Program of Cancer and Cell Biology of the College of Medicine by Jason M. Puglise M.Sc., Wright State University 2005 Committee Chair: Robert Brackenbury, Ph.D. ii ABSTRACT Puglise, Jason M. Ph.D., Cancer and Cell Biology Program. University of Cincinnati, 2010. Roles of the Rac/Cdc42 effector proteins Pak and PIX in cytokinesis, ciliogenesis, and cyst formation in renal epithelial cells. The p21-activated kinase 1 (Pak1) is a putative Rac/Cdc42 effector molecule and a multifunctional enzyme implicated in a wide range of cellular and biological activities. Although well-established as a regulator of cytoskeletal and microtubule dynamics, Pak1 influences centrosome behavior and plays a part in the cell cycle. We examine the role Pak1 and its binding partner Pak1-interacting exchange factor (PIX) play in centrosome dynamics and in cell cycle events in renal epithelial cells.
    [Show full text]